Skip to content

Effect of topical application of piroxicam gel, diclofenac gel and emla on pain relief

Comparison of the effect of topical application of piroxicam gel, diclofenac gel and emla on pain relief of angiocatheter insertion in patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180107038251N8
Enrollment
123
Registered
2023-06-12
Start date
2023-06-21
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intensity of pain. Pain, not elsewhere classified

Interventions

Intervention 1: Intervention group:Piroxicam (P), in the amount of 10 mg of piroxicam gel, is placed in the desired place (veins on the back of the hand) in dimensions of 2 x 4 cm. Intervention 2: Int

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age range from 15 to 65 years of old ASA I , II Absence of pain for any reason Absence of verbal, mental and visual disability Absence of pregnancy No history of drug abuse Not using painkillers in the last 24 hours Absence of sensitivity to NSAID Absence of sensitivity to local anesthetics Absence of allergy to vitamin A + D ointment

Exclusion criteria

Exclusion criteria: Lack of patient consent to participate or continue the study Body mass index more than 30 Presence of peripheral vascular disease and Raynaud's syndrome The presence of scleroderma Failure of the researcher in the first attempt at cannulation

Design outcomes

Primary

MeasureTime frame
Intensity of pain. Timepoint: at 0, 5, 10, 15, 30, and 45 minutes after cannulation. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazanin Amini

Arak University of Medical Sciences

nazaninamini69@yahoo.com+98 86 3417 3507

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026